ijms-logo

Journal Browser

Journal Browser

Induced Pluripotent Stem and Extracellular Vesicles in Biomedicine

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 260

Special Issue Editor


E-Mail Website
Guest Editor
Department of Innovative Technologies in Medicine and Dentistry, University “G. d’Annunzio” Chieti-Pescara, 66100 Chieti, Italy
Interests: stem cells; regenerative medicine; translational medicine; reprogramming

Special Issue Information

Dear Colleagues,

Induced pluripotent stem (iPS) cells are promising cell resources for tissue regeneration due to high self-renewal and pluripotency and fewer ethical issues than embryonic stem cells. iPS cells provide new methods for studying stemness and the differentiation process in tissue development. Therefore, having the same features as embryonic stem cells, iPS cells can differentiate into all adult cell lines, providing a new model for studying patient-specific diseases and offering innovative regenerative and translational medicine approaches.

However, despite the advantages of iPS cells, there are important limitations related to cell therapies, including immunogenicity. For this reason, research is currently focusing on studying vesicular products of stem cell secretomes, such as extracellular vesicles (EVs), as potential therapeutics that bypass the problems related to cell therapies. The study of EVs improves epigenetics knowledge to understand intercellular communication and the extracellular environment and can represent new approaches for cell-free therapies.

Authors are invited to contribute original research articles and reviews to this Special Issue, focusing on studies related to obtaining new iPS lines from different sources and their differentiation for translational medicine applications and also studying EVs’ epigenetic biological actions to identify new clinical potential.

Dr. Ylenia Della Rocca
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • induced pluripotent stem
  • embryonic stem cells
  • extracellular vesicles
  • tissue development
  • translational medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

25 pages, 17810 KiB  
Article
Autologous hGMSC-Derived iPS: A New Proposal for Tissue Regeneration
by Ylenia Della Rocca, Francesca Diomede, Fanì Konstantinidou, Valentina Gatta, Liborio Stuppia, Umberto Benedetto, Marco Zimarino, Paola Lanuti, Oriana Trubiani and Jacopo Pizzicannella
Int. J. Mol. Sci. 2024, 25(17), 9169; https://doi.org/10.3390/ijms25179169 (registering DOI) - 23 Aug 2024
Viewed by 168
Abstract
The high mortality in the global population due to chronic diseases highlights the urgency to identify effective alternative therapies. Regenerative medicine provides promising new approaches for this purpose, particularly in the use of induced pluripotent stem cells (iPSCs). The aim of the work [...] Read more.
The high mortality in the global population due to chronic diseases highlights the urgency to identify effective alternative therapies. Regenerative medicine provides promising new approaches for this purpose, particularly in the use of induced pluripotent stem cells (iPSCs). The aim of the work is to establish a new pluripotency cell line obtained for the first time by reprogramming human gingival mesenchymal stem cells (hGMSCs) by a non-integrating method. The hGMSC-derived iPS line characterization is performed through morphological analysis with optical and electron scanning microscopy and through the pluripotency markers expression evaluation in cytofluorimetry, immunofluorescence, and RT-PCR. To confirm the pluripotency of new hGMSC-derived iPS, the formation of embryoid bodies (EBs), as an alternative to the teratoma formation test, is studied in morphological analysis and through three germ layers’ markers’ expression in immunofluorescence and RT-PCR. At the end, a comparative study between parental hGMSCs and derived iPS cells is performed also for the extracellular vesicles (EVs) and their miRNA content. The new hGMSC-derived iPS line demonstrated to be pluripotent in all aspects, thus representing an innovative dynamic platform for personalized tissue regeneration. Full article
(This article belongs to the Special Issue Induced Pluripotent Stem and Extracellular Vesicles in Biomedicine)
Show Figures

Figure 1

Back to TopTop